In this final article of a series of five, Oxford Cannabinoid Technologies will discuss their expertise on the use of cannabinoids in medicine when it comes to treating COVID-19.
Christian Hendriksen, VP of International Expansion at Mile High Labs, illustrates how they are continuing compliance with the novel food application to ensure safe and effective cannabinoids can be available to all.
Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.
Canna CBD Limited shares with us 12 ways you can take cannabidiol (CBD), including oils, tinctures, pills, edibles, as well as products for localised relief like bath salts, lotions, roll-ons and creams.
John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.
A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.
Liam McGreevy, CEO of Ethnopharm Ltd, explains his thoughts on creating value in today’s maturing cannabis market, including how the firm can help both new and established businesses make sense of this.
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.
